Skip to main content

Advertisement

Table 1 Patient and treatment characteristics

From: Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis

  n %
Age
median 50
range 18-71
Gender   
male 37 76
female 12 24
T stage
1 7 14
2a 5 10
2b 19 39
3 8 16
4 10 20
N stage
0 10 20
1 12 24
2 21 43
3a 1 2
3b 5 10
Clinical stage
I 2 4
IIa 1 2
IIb 11 22
III 21 43
IVa 8 16
IVb 6 12
Histology
I 3 6
II 6 12
III 40 82
Concurrent CHT
cis weekly 31 63
carbo weekly 2 4
cis/5-FU 11 22
carbo/5-FU 4 8
5-FU 1 2
  1. Age [years], T, N and clinical stage according to 6th edition of the International Union against Cancer (UICC) TNM classification, histology according to world health organisation (WHO) classification, Cis: Cisplatin, Carbo: Carboplatin, 5-FU: 5-Fluorouracil, n: number of patients,%: percentage of the entire cohort, CHT: concurrent chemotherapy.